After a Steep Slide, IBM Stages a Comeback on Two Fronts — Cybersecurity and Silicon

IBM shares rally nearly 10% after OpenAI and Palo Alto Networks cyber pacts plus sub-1nm chip news, but consulting arm remains weak point with only 4% growth.

IBM shares stormed back from a mid-June rout to close the week at €237.80, notching a gain of nearly 10% in five sessions. The rally was powered by a one-two punch: a sweeping cyber alliance with OpenAI and Palo Alto Networks, and a jaw-dropping chip breakthrough that packed roughly 100 billion transistors onto a fingernail-sized sliver of silicon. Yet beneath the surface, the consulting arm that investors once leaned on remains a stubborn weak point.

The Security Pacts That Moved the Needle

The week's most concrete catalyst arrived on June 22, when IBM joined the OpenAI Daybreak Cyber Partner Program. The collaboration yields a new application security service that uses OpenAI models to hunt for software vulnerabilities — and then determines whether each hole is actually exploitable, a task that traditionally consumes hours of manual work by security teams. The service runs with read-only access to client code repositories through IBM Consulting Advantage.

That same day, IBM deepened its relationship with Palo Alto Networks and Red Hat. Together, the three companies are funneling $5 billion into Project Lightwell, a security infrastructure initiative that uses artificial intelligence to scan code for weaknesses at machine speed, with Palo Alto supplying a virtual patch function that lets firms close holes the same day they are found.

A Chip That Made Headlines — Then Faded

Hardware stole the spotlight as well. IBM unveiled the industry's first sub-1-nanometer chip technology, doubling transistor density compared with the 2021 predecessor. The announcement triggered an initial pop in the stock, but the excitement quickly dissipated when the company disclosed that volume production is still at least five years away and that a manufacturing partner has yet to be secured.

The fleeting chip rally was a reminder that near-term sentiment still hinges on revenue and earnings delivery, not blue-sky innovation.

Consulting Drag Meets Software Momentum

The stock's mid-June plunge was set off by Accenture, which cut the top end of its fiscal 2026 revenue forecast and dragged the entire IT services sector lower. IBM was especially vulnerable because 80% of its $12.5 billion generative AI backlog sits inside the consulting business. When enterprises delay IT spending, the consultancy feels the pinch first.

First-quarter results painted a split picture. Total revenue climbed 9% to $15.9 billion, with software up 11% and infrastructure surging 15%. Adjusted earnings per share hit $1.91, comfortably above the consensus estimate of $1.81. Free cash flow reached its highest level in a decade. But consulting managed only 4% growth — a lag that has analysts watching closely. An IBM-commissioned study underscored the concern: 91% of corporate leaders do not fully grasp their AI dependencies, and 71% struggle with vendor lock-in. Institutional analysts read that as a red flag for delayed large-scale AI deployments.

Technicals, Targets and the July 22 Hinge

Despite the week's bounce, the stock sits only 0.81% above its 200-day moving average of €235.90 — a level that now serves as key support. The relative strength index of 55.6 points to neutral-to-positive momentum, more recovery than breakout. On the upside, the shares trade 9% above the 50-day line, and Wedbush Securities and Barclays both maintain price targets of $350, citing strength in AI and cloud.

All eyes now turn to July 22, when IBM reports second-quarter earnings. The Street is looking for revenue of roughly $17.8 billion. The market will be watching for signs that consulting is regaining speed, that free cash flow is tracking toward CEO Arvind Krishna's target of roughly $1 billion more than 2025, and that the AI order book is still building. Krishna has held firm on his full-year guidance: currency-adjusted revenue growth of more than 5%.

Behind the scenes, IBM is also pushing ahead with a quantum chip fab project backed by billions in U.S. government funding — a longer-term bet that, like the sub-1nm chip, will take years to pay off. For now, the immediate narrative revolves around whether a $5 billion security bet and a string of software wins can carry the stock until consulting catches up.